Kopran Research Laboratories Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1986.
1986 Mumbai, Maharashtra, India Active
Last Updated:
About Kopran Research Laboratories Limited

Kopran Research Laboratories Limited, a active public limited company, was established on 12 August 1986 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1986PLC040601. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹22.50 Cr.

Formerly known as Kopran Formulations Private Limited, Kopran Formulations Limited. It upholds a compliant status. Employing 538 professional, Its leadership includes Sunita Banerji (Director), Rakesh Arunkumar Doshi (Director), Chandra Mohan Singhi (Whole-Time Director). Past directors included Sunita Banerji, Ajit Jain, Surendra Somani. It holds ₹194.00 Cr open charges and ₹39.50 Cr settled loans. Its latest AGM occurred on 10 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1076 Dr Emmoses Roadparijat House Worli, Mumbai, Maharashtra, 400018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH1986PLC040601

  • Registration Number

    040601

  • Incorporation Date

    12 August 1986

  • Authorized Capital

    ₹25.00 Cr

  • Paid-Up Capital

    ₹22.50 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 25.00 Cr
  • Paid Up Capital ₹ 22.50 Cr
  • Company Age 39 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 194.00 Cr
  • Satisfied Charges ₹ 39.50 Cr
  • Revenue Growth **** -0.89%
  • Profit Growth **** 141.52%
  • Ebitda **** 63.94%
  • Net Worth 9.37%
  • Total Assets **** 16.65%
Company report

Kopran Research Laboratories Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kopran Research Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kopran Research Laboratories Limited?
Current Directors
Name Designation Appointment Date Status
Sunita Banerji Director 01 Mar 2016 Current
Rakesh Arunkumar Doshi Director 14 Nov 2017 Current
Chandra Mohan Singhi Whole-Time Director 24 Jun 2015 Current
Vandana Surendra Somani Director 18 Feb 2015 Current
Mamta Ashok Biyani Director 14 Nov 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 12 Sep 2016 Past
Pramod Abcsdd Additional Director 15 Sep 2012 Past
Pramod Abcsdd Managing Director 24 Jun 2015 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 20 Dec 2011 Past
Pramod Abcsdd Director 18 Feb 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kopran Research Laboratories.

Kopran Research Laboratories Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 0.89% decrease. The company also saw a substantial improvement in profitability, with a 141.52% increase in profit. The company's net worth moved up by a moderate rise of 9.37%.

Kopran Research Laboratories revenue growth over time
Kopran Research Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-0.89%
*******
*******
*******
*******
Revenue from Operations
*******
-1.42%
*******
*******
*******
*******
Total Assets
*******
16.65%
*******
*******
*******
*******
Profit or Loss
*******
141.52%
*******
*******
*******
*******
Net Worth
*******
9.37%
*******
*******
*******
*******
EBITDA
*******
63.94%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kopran Research Laboratories?

In 2024, Kopran Research Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,940,000,000.00

Satisfied Charges

₹395,000,000.00

Charges Breakdown by Lending Institutions
  • Sbicap Trustee Company Limited : 124.75 Cr
  • State Bank Of India : 69.25 Cr
Latest Charge Details
Date Lender Amount Status
30 Jul 2020 State Bank Of India ₹69.25 Cr Open
09 May 2016 Sbicap Trustee Company Limited ₹124.75 Cr Open
04 May 2023 Others ₹28.00 Cr Satisfied
16 Mar 2021 Yes Bank Limited ₹11.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Kopran Research Laboratories?

Kopran Research Laboratories has a workforce of 538 employees as of Apr 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kopran Research Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kopran Research Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kopran Research Laboratories
Recent Activity within the Organization
  • Charges

    A charge registered on 04 May 2023 via Charge ID 100726717 with Others was fully satisfied on 23 Jun 2025. was recorded as a recent event.

  • Charges

    The activity A charge registered on 16 Mar 2021 via Charge ID 100437722 with Yes Bank Limited was fully satisfied on 14 May 2025. was completed.

  • Annual General Meeting

    Progress on Kopran Research Laboratories Limited last Annual general meeting of members was held on 10 Sep 2024 as per latest MCA records. was documented.

  • Director Appointment

    Progress on Deepika Nirmalsingh Mertia was appointed as a Company Secretary was appointed as a Company Secretary on 27 Aug 2024 & has been associated with this company since 1 year 5 months . was documented.

  • Charges

    A charge with State Bank Of India of Rs. 69.25 Cr registered on 30 Jul 2020 with Charge ID 100360412 was modified on 21 May 2024. was recorded as a recent event.

  • Balance Sheet

    Kopran Research Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kopran Research Laboratories Limited?

The CIN of Kopran Research Laboratories Limited is U24230MH1986PLC040601.

Where is Kopran Research Laboratories Limited headquartered?

Kopran Research Laboratories Limited is headquartered at 1076 Dr Emmoses Roadparijat House Worli, Mumbai, Maharashtra, 400018.

When was Kopran Research Laboratories Limited incorporated?

Kopran Research Laboratories Limited was incorporated on 12 August 1986.

Who are the current directors of Kopran Research Laboratories Limited?

The current directors of Kopran Research Laboratories Limited are

What is the primary industry of Kopran Research Laboratories Limited?

The primary industry of Kopran Research Laboratories Limited is Manufacturing.

Is Kopran Research Laboratories Limited a listed company?

Kopran Research Laboratories Limited is unlisted.

What is the capital structure of Kopran Research Laboratories Limited?

The authorized capital of Kopran Research Laboratories Limited is ₹25.00 Cr, and the paid-up capital is ₹22.50 Cr.

What is the compliance status of Kopran Research Laboratories Limited?

The compliance status of Kopran Research Laboratories Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available